The technologies monitor patient response to immunotherapies.
The firm is counting on its experience integrating data from the oil and gas industry to change the way pharmaceutical data scientists work.
Ahead of a longer-term goal to develop IVD kits, the company has a plan this year to allow early-access customers to take on one aspect of testing in their own labs.
The company is using money from a recent $3 million fundraise to package its Lyme disease test for use in settings like doctors' offices and pharmacy clinics.
The company sold shares, convertible debentures, and warrants to an institutional investor as part of a previously announced deal.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.